Carden D L, Korthuis R J
Department of Physiology and Biophysics, Louisiana State University Medical Center, School of Medicine, Shreveport 71130, USA.
Am J Physiol. 1996 Nov;271(5 Pt 2):H1947-52. doi: 10.1152/ajpheart.1996.271.5.H1947.
Neutrophils accumulate in skeletal muscle subjected to ischemia-reperfusion and appear to contribute to reperfusion-induced microvascular dysfunction. The overall objective of this study was to assess the role of the neutrophilic hydrolytic enzyme elastase in ischemia-reperfusion-induced granulocyte accumulation and microvascular dysfunction in skeletal muscle. We examined the effect of three structurally unrelated elastase inhibitors [eglin C, MeOsuc-Ala-Ala-Val-CH2Cl (MAAPV), or L-658758], administered at the onset of reperfusion, on neutrophil content and the increase in microvascular permeability induced by 4 h of ischemia and 0.5 h of reperfusion in the isolated canine gracilis muscle. Changes in vascular permeability (1 - sigma) were assessed by determining the solvent drag reflection coefficient for total plasma proteins (sigma) in the following groups: 1) 4.5 h of continuous perfusion (nonischemic), 2) ischemia-reperfusion alone, 3) ischemia-reperfusion + eglin C, 4) ischemia-reperfusion + MAAPV, and 5) ischemia-reperfusion + L-658758. Muscle neutrophil content was monitored by assessing tissue myeloperoxidase (MPO) activity in biopsies obtained at the end of the experiments. In nonischemic muscles, 1 - sigma and MPO activity averaged 0.13 +/- 0.03 and 0.7 +/- 0.2 units/g wet wt, respectively. Ischemia-reperfusion was associated with marked increases in microvascular permeability (1 - sigma = 0.39 +/- 0.02) and muscle MPO activity (8.9 +/- 1.2 units/g wet wt) that were attenuated by eglin C, MAAPV, and L-658758 (1 - sigma = 0.21 +/- 0.01, 0.22 +/- 0.02, and 0.21 +/- 0.03, respectively; MPO activity = 2.7 +/- 0.4, 2.1 +/- 0.8, and 2.8 +/- 1.8 units/g wet wt, respectively). These results suggest that granulocyte accumulation in postischemic skeletal muscle is dependent on the release of elastase from activated phagocytic cells. Moreover, neutrophilic elastase appears to play a major role in reperfusion-induced increases in microvascular permeability in skeletal muscle.
中性粒细胞在经历缺血再灌注的骨骼肌中聚集,并且似乎促成了再灌注诱导的微血管功能障碍。本研究的总体目标是评估嗜中性水解酶弹性蛋白酶在缺血再灌注诱导的粒细胞聚集以及骨骼肌微血管功能障碍中的作用。我们研究了三种结构不相关的弹性蛋白酶抑制剂[依格列净C、甲基琥珀酰-丙氨酸-丙氨酸-缬氨酸-氯甲基酮(MAAPV)或L-658758]在再灌注开始时给药,对分离的犬股薄肌中4小时缺血和0.5小时再灌注诱导的中性粒细胞含量以及微血管通透性增加的影响。通过测定以下组中总血浆蛋白的溶剂拖曳反射系数(σ)来评估血管通透性的变化(1 - σ):1)持续灌注4.5小时(非缺血),2)单独缺血再灌注,3)缺血再灌注 + 依格列净C,4)缺血再灌注 + MAAPV,5)缺血再灌注 + L-658758。通过评估实验结束时活检组织中的组织髓过氧化物酶(MPO)活性来监测肌肉中性粒细胞含量。在非缺血肌肉中,1 - σ和MPO活性分别平均为0.13±0.03和0.7±0.2单位/克湿重。缺血再灌注与微血管通透性显著增加(1 - σ = 0.39±0.02)和肌肉MPO活性(8.9±1.2单位/克湿重)相关,而依格列净C、MAAPV和L-658758可减弱这些变化(1 - σ分别为0.21±0.01、0.22±0.02和0.21±0.03;MPO活性分别为2.7±0.4、2.1±0.8和2.8±1.8单位/克湿重)。这些结果表明,缺血后骨骼肌中的粒细胞聚集依赖于活化吞噬细胞释放弹性蛋白酶。此外,嗜中性弹性蛋白酶似乎在再灌注诱导的骨骼肌微血管通透性增加中起主要作用。